Company News

Share this article:

Contract sales firm PDI announced new business wins exceeding $18 million, but would not divulge the new clients' names, based on contractual agreements, according to a spokesperson. The contracts include primary care, specialty and hospital settings sales teams, according to a statement. Reps will be deployed in June, and will call on hospital-based physicians specializing in women's health, primary care and pediatrics.

 

Eloquest Healthcare, a dermatology specialty company, partnered with Onset Therapeutics to market Optase, a topical prescription product for the treatment of decubitus ulcers, varicose ulcers and dehiscent wounds. Optase is one of two products joint-marketed by Onset Therapeutics and Eloquest Healthcare – the second is Exactacain, a topical anesthetic spray.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Allergan reported to seek out Salix deal

The Wall Street Journal says the deal would add "another layer of intrigue" to the Allergan-Valeant hostilities.

India's Marck gets FDA Warning Letter

Inspectors of Marck Biosciences found an array of problems during a October-November 2013 inspection, including mold near a sterile area that was so bad "the room had 'partially caved in.'"

DOJ closes Brilinta investigation

AstraZeneca announced the end of the investigation Tuesday.